10.11.2017 - Germany’s Boehringer Ingelheim is partnering US company Dicerna Pharmaceuticals to develop new RNAi therapeutics for liver diseases. The research collaboration and license...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)